About Global Pharma Regulatory Summit

CPhI Conferences and Informa Markets in India are delighted to announce the 10th annual Global Pharma Regulatory Summit as a virtual conference. A premier pharma regulatory event for the Indian generics and biosimilars industries, featuring timely programmed and relevant to technical and regulatory agenda. This summit will bring together pharma regulatory operations and submission professionals to learn best practices in the compilation, formatting and submission of a variety of approval applications. Top officials and subject-matter experts will share their knowledge and best practices on how to succeed in generic and biosimilar development, the regulatory process and approvals and the evolving policy landscape.

Who Should Partner

Enterprise Solutions

Regulatory Solutions

Pharma Consultants

Regulatory Software and Solutions

Data Management

Electronic Submission and Validation

Pharma Technology

Who Should Attend?

The 10^th Global Pharma Regulatory Summit will bring together leading Regulatory experts and decision makers from across the pharma industry. These delegates will be attending this summit to learn about the latest updates on regulations, best practice and compliance advances in the sector and much more.

The Global Pharma Regulatory Summit is designed for

Designations

VP’s / Directors / HODs

Sr. Managers / General Managers

Managers / Deputy Managers

Executives

Programme Focus

Regulatory Affairs in New Normal

Product Lifecycle Management

cGMP

Biosimilars

Nitrosamine

Impurity Profiling

Emerging Markets

Emergency Use Authorizations

Product Lifecycle Management: ICH Q12

cGMP Inspections Amid COVID-19 Pandemic

Remote Personal Interactions

Biosimilars in EU

Emerging Markets – China, Japan, Africa and Canada

Speakers

Dr. Boitumelo Semete-Makokotlela

Chief Executive Officer
South African Health Products Regulatory Authority

Cynthia Schnedar

EVP-Regulatory Compliance
Greenleaf Health and Former FDA

Dr. Joy St John

Executive Director
The Caribbean Public Health Agency

Dr. Kurt Brorson

Vice President-Regulatory & Access
Parexel and Former FDA

Philip crooker

Former Regulatory Counsel
US FDA

Dr. Praveen Kumar L

Head-Regulatory Affairs
Cipla

Robert Guidos

Executive Director-Pharma Regulatory Affairs & Strategic Alliances
Corning Incorporated and Former FDA

VIEW ALL SPEAKERS

Why Attend

Access the latest information and insights on global regulatory affairs program

Analyze how stakeholders around the world are supporting regulatory system optimization

Examine the impact of new initiatives for emerging markets

Network with innovators and opinion leaders in the pharma regulatory affairs arena

Glimpses & Testimonials

Quote This is my first CPhI as well as Virtual Conference and it was a very good experience. The exposure to Pharma Regulatory provided through this platform is what we were looking for and it met my professional needs Quote

Dr. Bharat D. Patel
Senior Manager, International Regulatory Affairs, Zydus Cadila Healthcare Limited

Quote Happy to have attended this summit as it was quite useful to us. We decided to attend this event seeing the quality of speakers and the attendee profile. Traditional sales in today’s times are not possible – virtual events are a way to do so, also a chance to understand the subject and get the attention of the attendees Quote

Sandeep Kulkarni
Co-Owner & Director, ImageProVision Technology Pvt Ltd.

Quote Selection of topics & presentations from the industry experts is the key factor which differentiates this conference from others. This is a very professional & well planned event Quote

Mr. Rakesh Jarwekar
Cipla Ltd.

Quote GPRS is one of the most important summit for spreading knowledge of regulatory professional. Nice arrangement and more important topics has been discussed by experts Quote

Mr. Md. Aby Kawsar
Eskayef, Pharmaceuticals Ltd.

Quote The conference was very useful to have an understanding of updated regulatory requirements for product registration and to exchange knowledge with industry leaders Quote

Sharmin Israt Khan
Beximco, Pharmaceuticals